Comparison of treatment initiation with bisoprolol vs. enalapril in chronic heart failure patients: rationale and design of CIBIS-III-Reference-Cited by-同舟云学术

Comparison of treatment initiation with bisoprolol vs. enalapril in chronic heart failure patients: rationale and design of CIBIS-III

Published:2004-06 Issue:4 Volume:6 Page:493-500
ISSN:1388-9842
Container-title:European Journal of Heart Failure
language:en
Short-container-title:European Journal of Heart Failure

Author:

Willenheimer Ronnie¹,Erdmann Erland²,Follath Ferenc³,Krum Henry⁴,Ponikowski Piotr⁵,Silke Bernard⁶,van Veldhuisen Dirk J.⁷,van de Ven Louis⁸,Verkenne Patricia⁸,Lechat Philippe⁹,

Affiliation:

1. Department of Cardiology; University Hospital; S-205 02 Malmö Sweden

2. Medizinische Klinik III; University of Cologne; Germany

3. Medicine A, University Hospital Zürich; Switzerland

4. Departments of Epidemiology and Preventive Medicine and Medicine; Monash University, Alfred Hospital; Melbourne Australia

5. Cardiology Department; Clinical Military Hospital; Wroclaw Poland

6. Department of Pharmacology and Therapeutics; Trinity Centre, St James’ Hospital; Dublin Ireland

7. Thoraxcenter, Department of Cardiology; University Hospital Groningen; The Netherlands

8. Merck KgaA; Darmstadt Germany

9. Service de Pharmacologie, Hopital Pitié-Salpetriere; Paris France

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Reference31 articles.

1. Pathophysiology of heart failure;Packer;Lancet,1992

2. Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative group on ACE inhibitor trials;Garg;J Am Med Assoc,1995

3. North of England evidence based development project: guideline for angiotensin converting enzyme inhibitors in primary care management of adults with symptomatic heart failure;Eccles;Br Med J,1998

4. The cardiac insufficiency bisoprolol study II (CIBIS II): a randomised trial;CIBIS II Investigators and Committees;Lancet,1999

5. Effect of metoprolol CR/XL in chronic heart failure: metoprolol CR/XL randomised intervention trial in congestive heart failure (MERIT-HF);MERIT-HF Study group;Lancet,1999

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cancer Mortality in Trials of Heart Failure With Reduced Ejection Fraction: A Systematic Review and Meta‐Analysis;Journal of the American Heart Association;2020-09-15

2. Pharmacological interventions for heart failure in people with chronic kidney disease;Cochrane Database of Systematic Reviews;2020-02-27

3. Efficacy and Safety of Angiotensin-Converting Enzyme Inhibitors in Patients With Left Ventricular Systolic Dysfunction and Hyponatremia;Journal of Cardiac Failure;2013-11

4. Influence of order and type of drug (bisoprolol vs. enalapril) on outcome and adverse events in patients with chronic heart failure: apost hocanalysis of the CIBIS-III trial;European Journal of Heart Failure;2011-07

5. Effect on Mode of Death of Heart Failure Treatment Started with Bisoprolol Followed by Enalapril, Compared to the Opposite Order: Results of the Randomized CIBIS III Trial;Cardiovascular Therapeutics;2011-02-24